tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market

Lexicon Pharmaceuticals (LXRX) Income Statement

Compare
1,498 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q3 2024), Lexicon Pharmaceuticals's total revenue was $1.75M, an increase of 980.25% from the same quarter last year. In Q3, Lexicon Pharmaceuticals's net income was $-64.81M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.20M$ 139.00K$ 298.00K$ 24.00M$ 322.07M
Gross Profit
$ 1.12M$ -288.00K$ -54.75M$ 22.07M$ 318.84M
Operating Expenses
$ 172.87M$ 100.90M$ 87.39M$ 200.85M$ 148.76M
Depreciation and Amortization
$ 554.00K$ 427.00K$ 292.00K$ 2.93M$ 3.65M
EBITDA
$ -163.46M$ -98.74M$ -86.66M$ -41.10M$ 173.74M
Operating Income
$ -171.75M$ -100.76M$ -87.09M$ -178.78M$ 141.44M
Other Income/Expenses
$ -5.37M$ -1.18M$ -668.00K$ -10.77M$ -17.33M
Pretax Income
$ -177.12M$ -101.94M$ -87.76M$ -58.57M$ 124.12M
Net Income
$ -177.12M$ -103.13M$ -88.27M$ -70.18M$ 130.13M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.80$ -0.62$ -0.61$ -0.63$ 1.23
Diluted EPS
$ -0.80$ -0.62$ -0.61$ -0.63$ 1.11
Weighted Average Shares Outstanding
221.13M 165.73M 145.65M 110.84M 106.22M
Weighted Average Shares Outstanding (Diluted)
221.13M 165.73M 145.65M 110.84M 116.75M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis